Idiopathic Pulmonary Fibrosis: Cellular and Molecular Pathogenesis
Overview
Authors
Affiliations
Diffuse involvement of the pulmonary interstitium with abnormal fibrous tissue is a process that occurs in many settings. There are many possible etiologies for pulmonary fibrosis, but in the majority of individuals, a clear cause cannot be determined and a diagnosis of idiopathic pulmonary fibrosis (IPF) results. Despite limited knowledge concerning the etiology, recent advances in biomedical technology offer great promise for increasing our understanding of IPF. This review will focus on current concepts of the pathogenesis and therapy of IPF.
FSP1-positive fibroblasts are adipogenic niche and regulate adipose homeostasis.
Zhang R, Gao Y, Zhao X, Gao M, Wu Y, Han Y PLoS Biol. 2018; 16(8):e2001493.
PMID: 30080858 PMC: 6078284. DOI: 10.1371/journal.pbio.2001493.
Asghari M, Hobbenaghi R, Nazarizadeh A, Mikaili P Res Pharm Sci. 2016; 10(5):429-35.
PMID: 26752991 PMC: 4691963.
Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.
Nho R Drug Dev Res. 2015; 76(7):343-53.
PMID: 26303294 PMC: 4615542. DOI: 10.1002/ddr.21272.
Preventive effects of pomegranate seed extract on bleomycin-induced pulmonary fibrosis in rat.
Hemmati A, Rezaie A, Darabpour P Jundishapur J Nat Pharm Prod. 2014; 8(2):76-80.
PMID: 24624192 PMC: 3941905.
Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.
Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K Respir Res. 2010; 11:31.
PMID: 20298567 PMC: 2846897. DOI: 10.1186/1465-9921-11-31.